The couple has been credited with the development of the drug lubiprostone, which is used to treat constipation and irritable bowel syndrome. Sachiko Kuno and her husband have also invested in a number of other businesses, including real estate, venture capital, and biotechnology. Their combined net worth of $330 million makes them one of the wealthiest couples in the world.
Sachiko Kuno is a Japanese American scientist and entrepreneur who has a net worth of $330 million. She and her husband Ryuji Ueno co-founded the pharmaceutical firms Sucampo Pharmaceuticals and R-Tech Ueno, and are credited with the development of the drug lubiprostone. In addition to their pharmaceutical investments, the couple has also invested in real estate, venture capital, and biotechnology, making them one of the wealthiest couples in the world.
Sachiko Kuno is a member of CEOs
Age, Biography and Wiki
💰 Net worth: $195 Million (2024)
Sachiko Kuno, a prominent figure in the business world, is estimated to have a net worth of around $195 million by the year 2024. Renowned as a successful CEO within the United States, Kuno has established herself as a trailblazing entrepreneur with a keen eye for innovation. Through her strategic decisions and leadership skills, she has steered companies towards excellence and achieved remarkable growth. Sachiko Kuno's remarkable net worth is a testament to her exceptional achievements and unwavering dedication to success within the business realm.
Kuno earned her Ph.D. in biochemical engineering. The couple moved from Japan to the United States in 1999 and now own two historic Georgetown mansions. She serves as CEO and co-founded the nonprofit S&R Foundation which supports individuals who are talented in the arts, sciences, and social entrepreneurship. Kuno was ranked #41 on the inaugural Forbes list of America's Richest Self-Made Women in 2015.
